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ETX1 is over-expressed in the glaucomatous trabecular meshwork
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Purpose: To determine whether exon-trapped X chromosome clone 1 (ETX1) is overexpressed in the trabecular meshwork
(TM) of glaucomatous human eyes compared to controls.
Methods: Immunohistochemical, western blot, and enzyme-linked immunosorbent assay analysis were used with human
tissues  and  TM  protein  extracts.  Reverse  transcription-PCR  was  performed  on  isolated  mRNA-derived  cDNA
preparations.
Results: Elevated expression levels of ETX1 were detected in glaucomatous compared to control TM tissue. This
corroborates previous detection of ETX1 in glaucomatous TM by proteomic analysis. ETX1 mRNA is present in TM tissue,
suggesting ETX1 protein is locally produced within TM cells.
Conclusions: This is the first report demonstrating overexpression of ETX1 in glaucomatous TM. ETX1 expression may
regulate  TM  protein  interactions  involved  in  cell  adhesion,  and  its  aberrant  overexpression  may  be  part  of  the
pathophysiological pathway in the development of glaucoma.
The glaucomas are a group of neurodegenerative ocular
diseases that affect over 70 million individuals worldwide
[1]. Glaucoma is characterized by irreversible damage to the
optic nerve and retinal ganglion cell death. Static perimetry is
used to determine visual field loss in the clinical assessment
of glaucoma [2,3]. The glaucomas are termed primary when
the etiology of optic nerve damage is unknown and secondary
when a mechanism for elevated intraocular pressure (IOP) can
be ascribed to the development of glaucoma. Primary open
angle glaucoma (POAG) is typically associated with elevated
IOP,  which  occurs  secondary  to  an  imbalance  between
aqueous humor production and outflow [4]. Aqueous humor
is a clear liquid secreted into the posterior chamber, is actively
produced  by  the  ciliary  epithelium,  and  exits  through  the
anterior  chamber  into  Schlemm’s  canal.  Aqueous  humor
provides vital nutritional support to anterior chamber tissues,
including the lens and the cornea. Aqueous humor outflow
experiences most resistance at a filter-like structural region
termed  the  trabecular  meshwork  (TM).  In  glaucoma,
resistance to outflow at the level of the TM is substantially
increased, resulting in increased IOP [5].
Exon-trapped X chromosome clone 1 (ETX1), a protein
of unknown function, was previously localized in retina and
identified as a candidate disease gene responsible for X-linked
retinitis pigmentosa (xlRP) [6]. This protein is also known as
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Sushi repeat-containing protein (SRPX; Swiss-Prot accession
number P78539 and Unigene identifier Hs. 15154). However
due to the presence of mutations in normal populations as well
as  those  with  xlRP,  gene  mutation  studies  could  not
conclusively demonstrate that ETX1 mutations are linked to
retinitis pigmentosa [6]. Proteomic analyses of surgical and
cadaveric  TM  demonstrated  the  presence  of  ETX1  in
glaucomatous  but  not  control  TM  tissue  [7].  This  initial
identification  of  ETX1  in  TM  tissue  using  proteomic
approaches  necessitated  validation  by  other  molecular
methods  and  determination  as  to  whether  the  protein  is
synthesized  locally  in  the  TM  or  transported  by  aqueous
humor to the TM from elsewhere in the anterior segment of
the eye.
To determine ETX1 protein localization in the eye and
probe  its  expression  levels,  we  produced  polyclonal
antibodies  against  specific  ETX1  peptides.  Using
immunohistochemical,  western  blot,  and  enzyme-linked
immunosorbent assay (ELISA) techniques, we demonstrated
the presence of ETX1 in the TM and retina. Using reverse
transcription (RT)-PCR, we demonstrated local expression of
ETX1 messenger RNA along with genetic analysis of ETX1
in glaucoma and normal donors.
METHODS
Tissue procurement: Human tissues were derived from donor
eyes from normal control and POAG cadavers, enucleated
within 8–12 h of death and obtained from the National Disease
Research Interchange (Philadelphia, PA). Glaucomatous eyes
with  documented  optic  neuropathy  and  progressive
deterioration in the visual field compatible with glaucoma
were procured. Control eyes were from normal donors that
lacked optic neuropathy and had no history of eye disease.
Both control and glaucomatous donors lacked major central
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2061nervous  system  disorders.  All  eyes  used  in  this  study
originated from Caucasian donors between 50–90 years of
age.
Western blot analysis: Protein was extracted from tissues by
homogenization in 125 mM Tris-Cl buffer pH 7.0 containing
100 mM NaCl and 0.1% sodium dodecyl sulfate (SDS) and 1
mM  dithiothreitol.  Insoluble  material  was  removed  by
centrifugation  (8,000×  g  for  5  min),  and  soluble  protein
quantified by the Bradford assay [8]. Western blot analyses
were performed with 10 µg of protein extract (unless stated
otherwise), electroblotting to polyvinylidene fluoride (PVDF)
membrane  and  probing  with  chicken  polyclonal  antibody
(Aves Lab Inc., Portland, OR) custom produced against CZ
SNF PEG DHK IQY TVY DRA ENK (residues #228–248 in
the ETX1 protein sequence named hSRPX#3). Secondary
goat  antichicken  IgY  was  used  for  detection.  Two  other
antibodies were also made: hSRPX#1 (against peptide CZ
DSP LED DEV GYS HPR YKD T; residues #36–54 in the
ETX1 protein sequence) and hSRPX#2 (against peptide CP
SVK ERI AEP NKL TVR VSW ET; residues #184–205 in
the ETX1 sequence), which were also used for ELISA and
western  blot  analysis.  For  all  analyses,  commercially
available 4–20% SDS-polyacrylamide gels (Invitrogen Inc.,
Carlsbad, CA) were used unless stated otherwise.
Enzyme-linked  immunosorbent  assay  analysis:  For
quantification  of  ETX1,  ELISA  was  performed  following
established  protocols  [9].  TM  protein  extracts  were
centrifuged at 10,000x g for 10 min, then transferred to wells
in a 96 well plate (Costar 9018 plate; catalog number 44-2504;
eBioscience Inc., San Diego, CA), and incubated for 20 min
at room temperature. The supernatant was discarded and the
plate was washed with PBS. Plates were blocked with 1%
BSA for 1 h, washed with PBS and incubated 1 h with ETX1
(hSRPX#3) primary antibody. Secondary antibody coupled
with  alkaline  phosphatase  was  used  for  primary  antibody
detection with one hour incubation period. The plate was then
washed with PBS, incubated with phosphatase substrate (100
µl /well) in diethanolamine buffer pH 7.5 and quantified at
405  nm  on  a  plate  reader  (BioTek  Synergy  HT,  BioTek
Instruments,  Inc.,  Winooski,  VT).  A  similar  analysis  was
performed  using  a  primary  rabbit  polyclonal
glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH)
loading control antibody (Sigma Chemical Co., St. Louis,
Figure 1. Localization of expression of
exon  trapped  X  chromosome  clone  1
(ETX1) in human trabecular meshwork.
A:  Merged  image  of  exon  trapped  X
chromosome  clone  1  (ETX1)  with
secondary Cy5 antibody (magenta) and
4',6-diamidino-2-phenylindole  (DAPI)
in  the  normal  trabecular  meshwork
(TM). B: The normal TM image stained
only for ETX1 (secondary coupled with
Cy5; magenta) C: The merged image
(ETX1  in  magenta)  in  glaucomatous
TM  as  indicated.  Glaucomatous  TM
shows increased expression of ETX1 as
compared  to  normal  TM  as  in  A.
D:Glaucomatous TM labeled by ETX1
antibody coupled to Cy5, with arrows
indicating  areas  of  hyperfluorescence
compared  to  normal  tissue.  SC,
Schlemm’s canal.
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2062MO). ETX1 immunoreactivity was normalized to GAPDH
immunoreactivity.
Immunohistochemical  analyses:  Cadaver  eyes  were  fixed
immediately after enucleation with calcium acetate buffered
4% paraformaldehyde and embedded in paraffin. Globes were
sectioned (10 µm) and incubated with 5% BlokHen (Aves labs
Inc.) in phosphate buffered saline (PBS). They were then first
incubated  with  10  ng  anti-ETX1  (hSRX#3)  antibody
overnight at 4 °C and subsequently with 10 ng secondary
antibody  conjugated  with  CY-5  (Molecular  Probes,
Invitrogen  Corporation,  Carlsbad,  CA)  for  1  h  at  room
temperature. Sections were sealed with Vectashield (Vector
Labs, Burlingame, CA) and analyzed with a Leica TSP-5
confocal microscope (Leica, Exton, PA). Five donor tissues
each for control and glaucomatous TM were examined. To
ensure identical processing and uniform exposure, control and
glaucomatous sections were examined side by side on the
same  slide.  A  series  of  1-µm  xy  (en  face)  images  were
collected and summed for an image representing a three-
dimensional projection of the entire 10-µm section. Confocal
microscopic panels were composed using AdobePhotoshop
5.5.
Reverse transcription-PCR analysis: RNA was isolated from
human TM lysates using Trizol (Invitrogen), and cDNA was
prepared using established protocols. cDNA samples were
PCR-cycled  at  a  modified  temperature  of  47.5  ºC  for
annealing using primer pair 5’-ACT CAA TGC CCC AGA
GAA TG-3’ and 5'-GAG CCG GTA AAG GAG GTT TC-3'.
The PCR products were separated on 2% agarose gels at 100
V for 80 min. The expected size of ETX1 is approximately 220
bp, determined with a 100-bp molecular weight ladder.
RESULTS
ETX1  is  localized  in  trabecular  meshwork  and  retina:
Immunohistochemical  analysis  identified  ETX1  protein
expression  in  the  TM  (Figure  1)  and  retina  (Figure  2).
Glaucomatous  TM  demonstrated  elevated  ETX1
immunoreactivity compared to normal TM (Figure 1A,B).
ETX1 immunoreactivity was visible near Schlemm’s canal
and throughout the TM (Figure 1C,D). The normal retina
demonstrated  more  cellular  expression  within  the  retinal
ganglion  cell  layer  (Figure  2A,B).  Glaucomatous  retina
showed  less  cellularity  as  judged  by  the  relative  lack  of
staining with 4',6-diamidino-2-phenylindole (DAPI; Figure
2C),  a  nuclear  marker.  However,  glaucomatous  retina
demonstrated large swaths of ETX1 staining at the level of the
Figure 2. Localization of expression of
ETX1  in  human  retina  by
immunofluorescence. A: Merged image
of ETX1 and DAPI in normal retina.
Retinal  ganglion  cell  (RGC)  layer  is
intact in the normal retina with good
cellularity.  B:  Normal  retina  stained
with  anti-ETX1  and  secondary
antichicken antibody coupled with Cy5.
C: Merged image of ETX1 and DAPI in
glaucomatous retina. RGC layer shows
decreased  cellularity  compared  to  the
normal.  D:  Staining  for  ETX1  in
glaucomatous retina. Clusters of ETX1
indicated with arrows are more frequent
and  cover  more  swaths  of  area  in
glaucomatous tissue in both the RGC
layer as well as diffusely throughout the
retina. RGC: Retinal ganglion cell; INL:
Inner nuclear layer; ONL: Outer nuclear
layer.
Molecular Vision 2009; 15:2061-2067 <http://www.molvis.org/molvis/v15/a221> © 2009 Molecular Vision
2063retinal ganglion cell (RGC Figure 2C,D). These swaths or
deposits of ETX1 are more frequent and appeared in larger
patches  in  the  glaucomatous  retina  compared  to  normal
control eyes (Figure 2B,D).
Elevated  expression  of  ETX1  in  glaucomatous  trabecular
meshwork: ETX protein expression was elevated in the TM
of  glaucoma  donor  tissues  compared  to  controls  (Figure
3A,C). Using western blot analysis, our antibody detected a
protein band of approximately 50 kDa corresponding to ETX1
in  the  TM.  This  protein  band  was  more  abundant  in
glaucomatous  tissue  compared  to  control  tissue  (Figure
3A,C). Notably, the ETX1 bands are visible in the normal TM
with much higher loading of proteins (Figure 3A,C). ELISA
analysis  of  TM  extracts  normalized  to  GAPDH
immunoreactivity  corroborates  this  finding  (Figure  4).
Western blot analysis detected four additional protein bands,
and except for one all the other bands were lower in molecular
weight  and  could  be  proteolytic  products  or  alternatively
spliced  variants  (Figure  3A,C).  The  protein  band  slightly
greater than 50 kDa could be post-translationally modified or
alternatively spliced ETX1 (Figure 3C). However the five
immunoreactive western blot bands show variation among
individuals and are also expressed among normal controls
(Figure 3C).
ETX1 in the trabecular meshwork is locally formed: RT-PCR
analysis showed the presence of ETX1 mRNA in the TM,
suggesting local transcription and translation for ETX1. Our
primer pair detected a 220 bp fragment, which was found in
both  normal  and  glaucomatous  TM  (Figure  5).  This  data
suggest ETX1 protein expressed in the TM is due to local
production and probably not an export product produced by
other ocular structures.
DISCUSSION
ETX1 mRNA was previously observed to be localized to the
retina.  ETX1  mutations  were  initially  identified  as  being
associated with X-linked retinitis pigmentosa (RP), but were
not conclusively linked to RP due to their presence in the
normal population as well [6,10,11]. Using proteomic analysis
we reported the presence of ETX1 protein for the first time in
the TM and identified ETX1 protein in the glaucomatous but
not normal TM [7]. The reported identification of ETX1 in
TM necessitated further validation by independent methods
and determination that the protein is locally produced and not
accumulated in the TM due to transport from elsewhere. As
Figure  3.  Western  blot  analysis  of
trabecular  meshwork  proteins.  TM
tissue extract (10 µg) was fractionated
on  a  4–20%  gradient  gel  (Invitrogen,
Carlsbad, CA). A: Western blot analysis
after  transfer  onto  a  polyvinylidene
fluoride  membrane.  The  blot  was
probed  with  17–20  µg  of  chicken
polyclonal  antibody  hSRPX#3
(generated against a synthetic peptide;
see methods). B: Western blot analysis
in normal controls with a protein load of
80  µg  and  probed  with  17–20  µg  of
chicken polyclonal antibody hSRPX#3.
C: Identical gel as in A stained with
Commassie blue R-250.
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2064revealed  in  our  present  studies,  the  previous  proteomic
detection of ETX1 in the glaucomatous TM is perhaps due to
elevated expression of ETX1 in the TM region and relative
low abundance in normal TM (Figure 1C, Figure 3, and Figure
4). ETX1 protein levels are elevated in glaucomatous TM
tissue even after correcting expression for the housekeeping
protein GAPDH (Figure 4).
ETX1 is a protein of unknown function, contains one
hyaline  repeat  (HYR),  and  three  interrupted  complement
control protein or sushi repeat domains but lacks C-type lectin
or  epidermal  growth  factor  domains  that  exclude  the
likelihood of the protein being a cell adhesion molecule. A
hyaline vascular system has been implicated in eye diseases
[12], including glaucoma [13]. In a differential screen, ETX1
has also been found to be differentially expressed in retinal
and choroidal microvascular endothelial cells [14]. ETX1 has
two spliced isoforms, 78539 and 78539-2. The ETX1 protein
is also referred to as Sushi repeat-containing protein. The X-
linked (Q4VX66) variant is 464 (451 for isoform 2) amino
acids long and has a theoretical molecular weight of 51,572
Da. Theoretical trypsin digestion of either isoform provides
about 88.1% coverage, generating identical peptides. Splice
variants therefore cannot be readily differentiated using in-gel
trypsin  digestion  and  mass  spectrometry.  Our  polyclonal
antibody (hSRPX#3), raised in chicken against a synthetic
peptide, cannot distinguish between the two isoforms, and
therefore multiple western blot protein bands were identified,
using our antibody. The protein band corresponding to 50 kDa
is the bonafide ETX1 (either isoform); the lower identified
molecular weight band may be a proteolytic product or an
alternative splice variant (Figure 3C). The single protein band
higher than 50 kDa identified in glaucomatous TM tissue can
either be a splice variant or a post-translationally modified
Figure 4. Enzyme-linked immunosorbent assay analysis using anti-
ETX1  on  proteins  from  normal  and  glaucomatous  trabecular
meshwork tissue. The ETX1 immunoreactivity was normalized to
GAPDH immunoreactivity determined in an identical fashion.
protein. Other homologues of ETX1, notably SRPX2, have
been implicated to have a role in speech and cognition, while
mutations  in  this  gene  have  been  associated  with  brain
disorders [15]. ETX1 has been conjectured to be involved in
phagocytosis during disk shedding, cell adhesion to cells other
than the pigment epithelium, or signal transduction and has
been localized to the surface of photoreceptor cells [6,10]. A
high degree of sequence conservation exists among Sushi
repeat proteins across different mammalian species, with over
89% identity and 92% similarity between mouse, rat, bovine,
and human. Differentially spliced isoforms of Sushi repeat-
containing proteins have amino acid lengths ranging between
358 and 459 (Table 1). The complement control protein (CCP)
module in ETX1 is implicated in protein–protein interactions
[16]  mediating  complement  component  interactions.
Complement component proteins have been shown to play a
role  in  glaucoma  [17]  and  members  of  complement
components have been detected in glaucomatous TM [7,18].
ETX1  is  possibly  upregulated  in  glaucomatous  TM  and
accumulates due to dysregulation of complement components
in glaucoma. ETX1 is possibly involved in regulation of the
cell adhesion in the TM, but dysregulation of ETX1 expression
occurs in glaucomatous TM, leading to its accumulation and
potential aberrant TM cell adhesion that may lead to increased
resistance to aqueous outflow. The ETX1-like proteins have
been reported to have tumor suppressor activity [19] and have
been found to be involved in growth inhibition. If ETX1 is
also contributory to growth inhibition, then that property of
ETX1, when it is overexpressed, will be potentially relevant
in  terms  of  contributing  to  decreased  cellularity  in  the
glaucomatous  TM.  Future  work  in  this  direction  will
Figure  5.  Representative  reverse  transcription-PCR  analysis  for
ETX1 in normal and glaucomatous trabecular meshwork tissues.
RNA was isolated from human TM lysates, using the Trizol method,
and cDNA was prepared using established protocols, as described in
the methods section. The PCR products were then run on a 2%
agarose gel at 100 V for 80 min. The expected size of ETX1 is
approximately 220 bp.
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2065demonstrate the function of ETX1 in TM tissue and whether
mutations in the ETX1 protein impair the fine regulation of
the complement system in glaucomatous TM, thereby playing
a pathophysiological role in the development of glaucoma.
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